3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Lymphoid
160
Other hematologic neoplasm
60
Plasma cell
37
Myeloid
35
Dermatologic
27
Breast
20
CNS
18
Sarcoma
13
Genitourinary
12
Classical hematology
12
Gynecologic
11
Gastrointestinal
8
Thoracic
7
Other solid neoplasm
3
Other
3
Other neoplasm
2
Head & Neck
2
Endocrine
2
NET
1
Conditions
Neuroendocrine Tumors
130
Gastro-enteropancreatic neuroendocrine tumor
16
Pancreatic Neoplasms
14
Neoplasms
12
Stomach Neoplasms
8
Carcinoma, Neuroendocrine
8
Carcinoid Tumor
8
Prostatic Neoplasms
7
Lung Neoplasms
7
Carcinoma, Hepatocellular
7
Breast Neoplasms
7
Thyroid Neoplasms
6
Melanoma
6
Esophageal Neoplasms
6
Colonic Neoplasms
6
Rectal Neoplasms
5
Pheochromocytoma
5
Neoplasm Metastasis
5
Gastrointestinal Stromal Tumors
5
Carcinoma
5
Adenoma, Islet Cell
5
Adenocarcinoma
5
Testicular Neoplasms
4
Skin Neoplasms
4
Serotonin Syndrome
4
Sarcoma
4
Paraganglioma
4
Liver Neoplasms
4
Kidney Neoplasms
4
Head and Neck Neoplasms
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Hodgkin Disease
×
NET
×
Clear all
NCT01135849
2015-11-17
B-Receptor Signaling in Cardiomyopathy
Stanford University
Completed
99 enrolled